Zydus Lifesciences Ltd., a leading Indian Pharmaceutical company, in its Q3 earnings call discussed strong performance across multiple segments, with US business
ZYDUSLIFE Q3 2024-2025 Call Highlights: Profit Jump, Robust Margins & Expansion Plans!
Categories
Health Care
DIVISLAB Q3 2024-2025 Call Highlights: Expansion Plans, Generics Growth, and API Challenges!
Divi's Laboratories Ltd., an Indian multinational pharmaceutical company that manufactures and exports API's, Intermediates and Nutraceutical ingredients, in its Q3 earnings call
Lupin Ltd Q3FY25; 39% rise in Profits
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations,
SUNPHARMA Q3 2024-2025 Call Highlights: India Leads, US Slows, Specialty Expands!
Sun Pharmaceutical Industries Ltd., the fourth largest specialty generic pharmaceutical company in the world, in its Q3 earnings call discussed about strong
Laurus Labs Ltd Q3FY25; 304% rise in Profits
Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active Pharmaceutical Ingredients
Krishna Institute of Medical Sciences Ltd Q3FY25; 19% rise in Profits
Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra
Jyothy Labs Ltd Q3FY25; 4% fall in Profits
Jyothy Labs Limited was founded in 1983 by Mr. M. P. Ramachandran in Thrissur, Kerala. JLL is renowned brand in the domestic
CIPLA Q3 2024-2025 Call Highlights: EBITDA Growth, Launch Delays, & Market Strategies!
Cipla Ltd., a leading pharmaceutical company from India that manufactures and distributes branded medicines, generics and active pharmaceutical ingredients across the globe,
Jubilant Pharmova Ltd Q3FY25; 53% rise in Profits
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary
Sun Pharmaceuticals Industries Ltd Q3FY25; 14% rise in Profits
Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations
DRREDDY Q3 2024-2025 Call Highlights: Record EBITDA, New Launches & Biosimilar Milestones!
Dr Reddy's Laboratories Ltd., an integrated global pharmaceutical company, in its Q3 earnings call discussed a 16% growth in India despite weakness
TORNTPHARM Q3 2024-2025 Call Highlights: Margins Surge, India Growth, & Insulin Recovery!
Torrent Pharmaceuticals Ltd., a leading pharma company in India, in its Q3 earnings call addressed that it expects to maintain a 32.5%
Torrent Pharmaceuticals Ltd Q3FY25; 14% rise in Profits
Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Ipca Laboratories Ltd Q2FY25; 81% rise in Profits
Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q2FY25 of ₹2,355.00
Sanofi India Ltd Q2FY25; 46% fall in Profits
Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for
Rainbow Childrens Medicare Ltd Q2FY25; 25% rise in Profits
Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of
Narayana Hrudayalaya Ltd Q2FY25; 12% fall in Profits
Narayana Hrudalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across
Natco Pharma Ltd Q2FY25; 83% rise in Profits
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products
Metropolis Healthcare Ltd Q2FY25; 31% rise in Profits
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South
Max Healthcare Institute Ltd Q2FY25; 2% rise in Profits
Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and
Mankind Pharma Ltd Q2FY25; 34% rise in Profits
Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer